Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Attention-deficit hyperactivity disorder (ADHD) affects an estimated 5–7 % of schoolchildren worldwide. School functioning and academic achievement are frequently impaired by ADHD and represent one of the main reasons children start ADHD medication. Multiple potential causal pathways exist between ADHD and impaired school performance. In this review, we decompose school performance into three components and assess the impact of ADHD and its treatments on academic performance (assessed by grade point average [GPA], time on-task, percentage of work completed as well as percent completed correctly), academic skills (as measured by achievement tests and cognitive measures), and academic enablers (such as study skills, motivation, engagement, classroom behavior and interpersonal skills). Most studies examined only the short-term effects of medication on school performance. In these, ADHD medications have been observed to improve some aspects of school performance, with the largest impact on measures of academic performance such as seatwork productivity and on-task performance. In a subset of children, these benefits may translate into detectable improvements in GPA and achievement testing. However, limited data exists to support whether these changes are sustained over years. Optimizing medication effects requires periodic reassessment of school performance, necessitating a collaborative effort involving patients, parents, school staff and prescribers. Even with systematic reassessment, behavioral-based treatments and additional school-based services may be needed to maximize academic performance for the many youth with ADHD and prominent impairments in school performance.

Original languageEnglish (US)
Pages (from-to)459-477
Number of pages19
JournalPediatric Drugs
Volume17
Issue number6
DOIs
StatePublished - Dec 1 2015

Fingerprint

Attention Deficit Disorder with Hyperactivity
School Health Services
Task Performance and Analysis
Motivation
Parents
Efficiency
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Pharmacology (medical)

Cite this

@article{ad55c9d2240a41e08be57f3189e86de2,
title = "Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?",
abstract = "Attention-deficit hyperactivity disorder (ADHD) affects an estimated 5–7 {\%} of schoolchildren worldwide. School functioning and academic achievement are frequently impaired by ADHD and represent one of the main reasons children start ADHD medication. Multiple potential causal pathways exist between ADHD and impaired school performance. In this review, we decompose school performance into three components and assess the impact of ADHD and its treatments on academic performance (assessed by grade point average [GPA], time on-task, percentage of work completed as well as percent completed correctly), academic skills (as measured by achievement tests and cognitive measures), and academic enablers (such as study skills, motivation, engagement, classroom behavior and interpersonal skills). Most studies examined only the short-term effects of medication on school performance. In these, ADHD medications have been observed to improve some aspects of school performance, with the largest impact on measures of academic performance such as seatwork productivity and on-task performance. In a subset of children, these benefits may translate into detectable improvements in GPA and achievement testing. However, limited data exists to support whether these changes are sustained over years. Optimizing medication effects requires periodic reassessment of school performance, necessitating a collaborative effort involving patients, parents, school staff and prescribers. Even with systematic reassessment, behavioral-based treatments and additional school-based services may be needed to maximize academic performance for the many youth with ADHD and prominent impairments in school performance.",
author = "Raman Baweja and Richard Mattison and James Waxmonsky",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s40272-015-0144-2",
language = "English (US)",
volume = "17",
pages = "459--477",
journal = "Paediatric Drugs",
issn = "1174-5878",
publisher = "Adis International Ltd",
number = "6",

}

TY - JOUR

T1 - Impact of Attention-Deficit Hyperactivity Disorder on School Performance

T2 - What are the Effects of Medication?

AU - Baweja, Raman

AU - Mattison, Richard

AU - Waxmonsky, James

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Attention-deficit hyperactivity disorder (ADHD) affects an estimated 5–7 % of schoolchildren worldwide. School functioning and academic achievement are frequently impaired by ADHD and represent one of the main reasons children start ADHD medication. Multiple potential causal pathways exist between ADHD and impaired school performance. In this review, we decompose school performance into three components and assess the impact of ADHD and its treatments on academic performance (assessed by grade point average [GPA], time on-task, percentage of work completed as well as percent completed correctly), academic skills (as measured by achievement tests and cognitive measures), and academic enablers (such as study skills, motivation, engagement, classroom behavior and interpersonal skills). Most studies examined only the short-term effects of medication on school performance. In these, ADHD medications have been observed to improve some aspects of school performance, with the largest impact on measures of academic performance such as seatwork productivity and on-task performance. In a subset of children, these benefits may translate into detectable improvements in GPA and achievement testing. However, limited data exists to support whether these changes are sustained over years. Optimizing medication effects requires periodic reassessment of school performance, necessitating a collaborative effort involving patients, parents, school staff and prescribers. Even with systematic reassessment, behavioral-based treatments and additional school-based services may be needed to maximize academic performance for the many youth with ADHD and prominent impairments in school performance.

AB - Attention-deficit hyperactivity disorder (ADHD) affects an estimated 5–7 % of schoolchildren worldwide. School functioning and academic achievement are frequently impaired by ADHD and represent one of the main reasons children start ADHD medication. Multiple potential causal pathways exist between ADHD and impaired school performance. In this review, we decompose school performance into three components and assess the impact of ADHD and its treatments on academic performance (assessed by grade point average [GPA], time on-task, percentage of work completed as well as percent completed correctly), academic skills (as measured by achievement tests and cognitive measures), and academic enablers (such as study skills, motivation, engagement, classroom behavior and interpersonal skills). Most studies examined only the short-term effects of medication on school performance. In these, ADHD medications have been observed to improve some aspects of school performance, with the largest impact on measures of academic performance such as seatwork productivity and on-task performance. In a subset of children, these benefits may translate into detectable improvements in GPA and achievement testing. However, limited data exists to support whether these changes are sustained over years. Optimizing medication effects requires periodic reassessment of school performance, necessitating a collaborative effort involving patients, parents, school staff and prescribers. Even with systematic reassessment, behavioral-based treatments and additional school-based services may be needed to maximize academic performance for the many youth with ADHD and prominent impairments in school performance.

UR - http://www.scopus.com/inward/record.url?scp=84947614982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947614982&partnerID=8YFLogxK

U2 - 10.1007/s40272-015-0144-2

DO - 10.1007/s40272-015-0144-2

M3 - Review article

C2 - 26259966

AN - SCOPUS:84947614982

VL - 17

SP - 459

EP - 477

JO - Paediatric Drugs

JF - Paediatric Drugs

SN - 1174-5878

IS - 6

ER -